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ABSTRACT
Objective To do a quantitative systematic review,
including published and unpublished data, examining
the associations between individual objective measures
of physical capability (grip strength, walking speed, chair
rising, and standing balance times) and mortality in
community dwelling populations.
Design Systematic review and meta-analysis.
Data sources Relevant studies published by May 2009
identified through literature searches using Embase (from
1980) and Medline (from 1950) and manual searching of
reference lists; unpublished results were obtained from
study investigators.
Study selection Eligible observational studies were those
done in community dwelling people of any age that
examined the association of at least one of the specified
measures of physical capability (grip strength, walking
speed, chair rises, or standing balance) with mortality.
Data synthesis Effect estimates obtained were pooled by
using random effects meta-analysis models with
heterogeneity between studies investigated.
Results Although heterogeneity was detected, consistent
evidence was found of associations between all four
measures of physical capability and mortality; those
people who performed less well in these tests were found
to be at higher risk of all causemortality. For example, the
summary hazard ratio for mortality comparing the
weakest with the strongest quarter of grip strength (14
studies, 53476 participants) was 1.67 (95% confidence
interval 1.45 to 1.93) after adjustment for age, sex, and
body size (I2=84.0%, 95% confidence interval 74% to
90%; P fromQ statistic <0.001). The summary hazard ratio
for mortality comparing the slowest with the fastest
quarter of walking speed (five studies, 14692
participants) was 2.87 (2.22 to 3.72) (I2=25.2%, 0% to
70%; P=0.25) after similar adjustments. Whereas studies
of the associations of walking speed, chair rising, and
standing balance with mortality have only been done in
older populations (average age over 70 years), the
association of grip strength with mortality was also found
in younger populations (five studies had an average age
under 60 years).
Conclusions Objective measures of physical capability
are predictors of all cause mortality in older community
dwelling populations. Such measures may therefore
provide useful tools for identifying older people at higher
risk of death.
INTRODUCTION
Physical capability, a term used to describe a person’s
ability to do the physical tasks of everyday living,1 can
be assessed by self report or objectively by using tests
such as grip strength, walking speed, chair rising, and
standing balance. Growing evidence from single stu-
dies suggests that these objective measures of physical
capability are also useful markers of current and future
health. As a result, interest is increasing in these tests
and their potential use as simple screening tools in the
general population to identify people whomay benefit
from targeted intervention (such as strength training)
or among patient groups to assess response to
treatment.2 3
No systematic review of the literature has been done
to examine the associations of walking speed, standing
balance, or chair rises with mortality. Existing reviews
of grip strength have not done meta-analyses of results
or investigated heterogeneity between studies.4 5
Whether associations are restricted to older popula-
tions with comorbidities that adversely affect physical
capability and increase risk of death or are also found
when physical capability is assessed in other popula-
tions, including those that are younger, thus remains
unclear.
Wedid a systematic review to test the hypothesis that
lower levels of physical capability in community dwell-
ing populations would be associated with higher sub-
sequent risk of poor health andmortality. In this paper,
we focus on all cause mortality as the end point. We
aimed to do meta-analyses of results acquired from
published studies and through contact with authors of
studies to obtain estimates of the size of the associations
of grip strength, walking speed, chair rise time, and
standing balance performance with mortality. We
also investigated whether these associations varied by
sex, age at baseline, length of follow-up, or country of
study.
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METHODS
We did a systematic review of existing literature, fol-
lowing the meta-analysis of observational studies in
epidemiology (MOOSE) guidelines and the PRISMA
statement.6 7
Search strategy and selection criteria
Eligible observational studies were those done in peo-
ple of any age living in the community that examined
the association of at least one of the specified measures
of physical capability (grip strength, walking speed,
chair rises, or standing balance) with mortality (full
review protocol available on request). We excluded
studies of patient groups.
RC searched the electronic databasesMedline (from
1950) and Embase (from 1980) to May 2009 by using
free text search terms (see web appendix) with no
restrictions by language. The initial search included
search terms for other selected health outcomes, but
those results are reported elsewhere.8
Figure 1 summarises the initial identification of stu-
dies. Combining the results of the electronic searches
and removing duplicate records left abstracts of 2270
unique records to be screened independently by two
authors (RC and RH). Examining the full text of 57
potentially eligible papers led to the identification of
25 papers with mortality as an outcome that were eli-
gible for inclusion.9-33 RC and RH independently
extracted the following data from these papers by
using a standardised form: relevant published results;
study population, selection, and baseline characteris-
tics; study exclusion criteria; details of methods for
ascertaining physical capability and mortality; and
adjustments made for potential confounders. RC and
RHmade an assessment of each study’s quality on the
basis of a modified version of the Newcastle-Ottawa
quality assessment scale34; however, no studies were
excluded on the basis of this assessment. The same
two authors independently searched the reference
lists of all eligible papers and identified a further 64
abstracts to screen, resulting in the identification of a
further three papers thatwere eligible for inclusion.35-37
Disagreements about the eligibility of a study or differ-
ences between the two sets of information extracted
were resolved through discussion.
Contact with study authors
We contacted the corresponding authors of 23 of the
28 eligible papers and asked them to complete standar-
dised results tables (copies available on request) (fig 2).
Of the five papers for which authors were not con-
tacted, we could not find up to date contact details for
two,15 22 the third had used the same study population
as other authors being contacted but had shorter fol-
low-up,35 and a further two were not identified until
after the deadline for contacting authors.27 28
Citations identified and screened (n=2270)
Citations excluded on basis of content of title and abstract (n=2213)
Papers retrieved for detailed assessment (n=57)
Citations excluded on basis of content of title and abstract (n=43)
Papers retrieved for detailed assessment (n=21)
Papers for full data extraction (n=35) (25 examined mortality)
Additional citations identified from reference lists of 35 eligible papers (n=64)
Papers for inclusion in reviews (n=43)
Papers for inclusion in mortality review (n=28)
Papers excluded (n=22):
  Letter to editor, no new results (n=1)
  Examined outcome that was not eligible (n=1)
  Cross sectional (n=7)
  Non-community dwelling populations (n=2)
  No clearly defined outcome (n=1)
  Review paper; no new results (n=1)
  Had relevant measures but did not examine association of interest (n=2)
  Used composite score of physical performance (n=7)
Papers for full data extraction (n=8) (3 examined mortality)
Papers excluded (n=13):
  Did not examine relevant physical capability measure (n=6)
  Used composite score of physical performance (n=4)
  Non-community dwelling population (n=1)
  Did not present relevant results (n=1)
  Had insufficient events  for analysis (only 6 deaths) (n=1)
Fig 1 | Flow diagram for identification of published studies. Includes identification of studies for
additional review of other health outcomes, reported elsewhere8
Eligible papers identified (n=28)
Sets of results (n=33):
  Grip strength (n=23)
  Walking speed/time (n=15)
Chair rises (n=7)
Standing balance (n=5)
Authors of papers contacted (n=23)
Sets of standard results provided (n=12)
Additional studies identified that
may have necessary data (n=9)
Sets of standard results provided (n=5)
Sets of published
results (n=16)
Sets of standard
results (n=17)
Authors not contacted (n=5)
Authors responded to say that unable or unwilling
  to provide results (n=5)
No response from authors (n=6)
Fig 2 | Flow diagram showing contact with authors and
ascertainment of results for inclusion in review
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We asked authors to analyse the associations
between each individual measure of physical capabil-
ity available and all causemortality, using survival ana-
lyses where possible, on men and women separately
and also combined. We requested three separate sets
of models: unadjusted, age adjusted, and age and body
size (height and weight or body mass index) adjusted,
with the addition of sex in the second and thirdmodels
when run on men and women combined. For all cap-
abilitymeasures, we asked authors for a comparison of
sex specific quarters with the best performing group
used as the reference category. For grip strength, we
also asked authors to provide estimates for a one unit
increase (we did not request estimates for a one unit
increase for the other three capability measures
because of the variation in the units of measurement).
After sending one reminder, we received responses to
17 of the 23 requests and 12 standard sets of results
were provided; the other five responses informed us
of the author’s inability to provide results (fig 2).
We also contacted the corresponding authors of a
further nine papers identified during screening of
abstracts as having potentially relevant data but who
had not published results from tests of the association
between physical capability measures and
mortality.38-46 This resulted in five sets of additional
results for inclusion (fig 2).
Statistical methods
We based analyses on the standard requested results if
they had been provided, using published results when
requested results were not available. If necessary, we
converted effect estimates for a per unit change in grip
strength to a per 1 kg increase in grip strength.
When more than three sets of comparable results
were available, we did random effects meta-
analyses.47 We ran these analyses first on the sex and
age adjusted estimates and then with additional adjust-
ment for body size. We then added estimates from
models with alternative adjustments into themeta-ana-
lysis for those studies (n=4) for which standard adjust-
ments were not available; this was the case only for
analyses of per unit change in grip strength. In all
these initial analyses, we used the combined sex
adjusted effects for men and women when they were
available and the sex specific estimates only when they
were not. We used I2 and Q statistics to investigate
between study heterogeneity.48 49We examined poten-
tial sources of heterogeneity, including sex, mean age
of study participants, length of follow-up, and region of
study (as pre-specified in the protocol), by stratifying
meta-analyses by each of these factors and by doing
meta-regression analyses when we had more than 10
sets of results.50 We used permutation tests to obtain P
values corrected for multiple testing.51 We also re-ran
the main meta-analyses with each study removed in
turn to check that no one study was explaining any
heterogeneity found. We examined funnel plots to
assess publication bias.52 We also used the tests pro-
posed by Egger and colleagues and Begg andMazum-
dar for this purpose.53 54
RESULTS
Study characteristics
Weconsideredmost of the studies to be of good quality
(web table A). This was partly because physical cap-
ability was usually measured by trained professionals
either in a home or clinic setting and mortality was
ascertained by methods considered to be reliable,
such as record linkage which usually results in little
loss to follow-up.
Most studies were done in older populations (web
table A and tables 1 and 3). None of the studies that
reported on associations of walking speed, chair rises,
or standing balance with mortality was in a population
with an average age under 61 years, and in most the
average age was over 70 years. Studies of grip strength
and mortality covered a wider range of ages, and five
had an average age of under 60 years.
Although similar numbers of studies of grip strength
and mortality had short (≤5 years), intermediate
(6-20 years), and longer (>20 years) follow-up, follow-
up in studies of walking speed has usually been five
years or less (no studies reported follow-up of more
than 10 years), and in studies of chair rises follow-up
has usually beenbetween six and 10 years (tables 1 and
3). Most studies have been done in the United States,
but studies have also been done across Europe and in
Japan, Hong Kong, and Australia.
Althoughwe did not assess the protocols formeasur-
ing physical capability used in different studies as part
of our review, we did record that a range of different
instruments have been used to measure grip strength.
Most of these instruments are different types of hand-
held dynamometer, and authors tend to use either the
maximum value recorded or the average achieved
over a fixed number of trials in their models. Walking
speed has been measured in different studies over dis-
tances of 4, 6, and 10 metres and 8 and 16 feet. Of the
studies of chair rises identified, all had asked partici-
pants to do five rises.
We had a total of 33 sets of results for consideration
in this review, consisting of 16 sets of published results
and17 sets of results in a specified format (web tableA).
Grip strength was the most frequently examined mea-
sure in the published literature; 19 of the 28 papers
identified reported on the association of this measure
withmortality. Fourteen papers reported results for the
association betweenwalking speed or time andmortal-
ity, four reported on standing balance, and three
reported on chair rises. Of the five additional studies
included after contact with authors, four provided
results for grip strength, two for walking speed, four
for chair rises, and one for standing balance.
Assessment of publication bias
Examination of funnel plots suggested no clear evi-
dence of publication bias. This was confirmed by the
results from tests proposed by Egger and colleagues
andBegg andMazumdar,53 54 which producedP values
of 0.28 or greater.
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Grip strength and mortality
A total of 23 sets of results from tests of the association
between grip strength and mortality were available,
and these were all from unique studies with the excep-
tion of one study (the Honolulu Heart Program). Dif-
ferent authors used this one study to contribute two sets
of results, but as one author provided effect estimates
for the per unit change in grip strength and the other
provided results of comparisons between quarters,25 33
we could include both in meta-analyses without the
same study population being included more than
once in the same meta-analysis.
Meta-analysis of the association between a unit
change in grip strength and mortality was based on
13 studies, one of which contributed two data points
as men and women had been analysed separately
(fig 3).30 Two other studies were not included: one
because it had used the sum of grip strength in both
hands,21 when all other studies had used themaximum
measure achieved in one hand or an average per hand,
and the other because grip strength hadbeenmeasured
in N/m2 rather than kg.26 (We instead included these
two studies in the meta-analyses of comparisons of
quarters described below.)
Most of the 13 studies (with a total of 44 636 partici-
pants) included in this first meta-analysis found that
higher grip strength was associated with lower subse-
quent mortality; the overall summary hazard ratio of
Table 2 | Summary of results from studies of grip strength not included in meta-analyses
Study name and reference/s*
Total No (No of
deaths)
Category comparison/value of
unit change Effect estimate (95% CI) Adjustments
Prospective Japanese study, Fujita
et al 199515
Men 2068 (113);
women: 1988
(42)
Low vhighperformance (as judged
against a standard)
Relative risk: men 1.92 (1.16 to
3.16); women 0.84 (0.38 to 1.86)
Age
EVERGREEN project, Laukkanen et
al 199520
463 (74) Below v above mean Odds ratio 1.86 (1.13 to 3.07) Age, sex
Edinburgh Longitudinal Study of
Ageing, Milne and Maule 198422
483 (135) NA No effect estimates presented—
mean baseline grip strength lower
in people who died during follow-
up than in those who survived
NA
Precipitating Events Project,
Rothman et al 200828
754 (283) Weak (that is, lower than sex and
body mass index specific
threshold) v not weak
Hazard ratio: 1.8 (1.3 to 2.5) Age, sex, race,
education, chronic
conditions
NA=not available.
*See web table A for further details of studies.
Table 1 | Results from stratified meta-analyses of age, sex, and body size adjusted hazard ratios of associations of grip
strength with all cause mortality
Stratification
Per 1 kg increase Lowest v highest quarter comparison
No*
Summary hazard
ratio† (95% CI) I2 (%) P value‡ No*
Summary hazard
ratio (95% CI) I2 (%) P value‡
None 14 0.97 (0.97 to 0.98) 89.5 <0.01 14 1.67 (1.45 to 1.93) 84.0 <0.01
Mean age at baseline
(years):
≤60 3 0.97 (0.97 to 0.98) 13.7 0.31 4 1.43 (1.07 to 1.91) 86.4 <0.01
61-70 4 0.97 (0.94 to 1.01) 90.7 <0.01 2 1.81 (0.73 to 4.49) 68.0 0.08
>70 7 0.97 (0.96 to 0.98) 90.5 <0.01 8 1.80 (1.48 to 2.18) 81.9 <0.01
Length of follow-up (years):
≤5 5 0.96 (0.95 to 0.97) 39.7 0.16 5 2.16 (1.70 to 2.75) 31.9 0.21
6-10 4 0.98 (0.95 to 1.00) 95.8 <0.01 2 2.26 (1.88 to 2.72) 0 0.70
11-20 2 0.97 (0.97 to 0.98) 0 0.34 2 1.43 (1.33 to 1.54) 0 0.91
>20 3 0.98 (0.97 to 0.99) 90.7 <0.01 5 1.39 (1.15 to 1.70) 81.9 <0.01
Region of study:
North America 8 0.97 (0.96 to 0.97) 60.4 0.01 7 1.64 (1.35 to 2.01) 89.1 <0.01
Japan 4 0.99 (0.97 to 1.00) 87.1 <0.01 1 1.98 (1.64 to 2.40) – –
Other 2 0.98 (0.94 to 1.01) 72.3 0.06 6 1.64 (1.31 to 2.06) 59.1 0.03
Sex§:
Male 10 0.97 (0.96 to 0.98) 91.6 <0.01 12 1.75 (1.41 to 2.16) 83.5 <0.01
Female 9 0.97 (0.96 to 0.98) 71.3 <0.01 10 1.46 (1.29 to 1.66) 34.2 0.13
*Number of data points.
†4/14 estimates included are from models with multiple adjustments rather than standard adjustments of age, sex, and body size.
‡From Cochran’s Q statistic.
§Total numbers differ for sex stratified meta-analyses for following reasons: per unit grip strength estimates include three studies of men only, two of
women only, and two that had combined both sexes and did not have sex specific estimates also available (unstratified summary hazard ratio for
comparison with sex stratified estimates 0.97 (0.96 to 0.98), n=19, I2=86.6%, P<0.01); grip strength quarter comparison estimates include four
studies of men only and two of women only (unstratified summary hazard ratio for comparison 1.61 (1.43 to 1.81), n=22, I2=73.9%, P<0.01).
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mortality associated with a 1 kg increase in grip
strength estimated from a random effects model was
0.97 (95% confidence interval 0.96 to 0.98) with adjust-
ment for age, sex (where appropriate), and body size or
withmultiple adjustments for four studies (see footnote
to fig 3). Although all effect estimates were in the same
direction,we found evidence of heterogeneity between
studies (I2=89.5%, 95% confidence interval 84% to
93%; P from Q statistic<0.001). However, when we
stratified the meta-analyses by the pre-specified char-
acteristics and did meta-regression analyses we found
no clear evidence that any of these factors explained
the heterogeneity (table 1). Removal of each study
from the meta-analyses did not greatly affect estimates
of the level of heterogeneity (results not shown). Find-
ings were similar when we analysed results frommod-
els adjusted for age and sex only.
Effect estimates from 14 studies (53 476 participants)
that had compared quarters of grip strengthwere avail-
able for inclusion inmeta-analyses (fig 4).Most of these
studies found that people in the weakest sex specific
quarter of grip strength had significantly higher rates
of mortality than did those in the strongest quarter; the
overall summary hazard ratio of mortality comparing
the lowest with the highest quarter was 1.67 (1.45 to
1.93) with adjustment for age, sex, and body size. Sum-
mary hazard ratios from the meta-analyses of effect
estimates comparing the second weakest and second
strongest quarter with the strongest quarter showed a
graded effect (fig 5).
  Al Snih (B) (2488; 507)
  Cawthon and Ensrud (MrOS) (M) (5631; 1070)
  Cawthon and Ensrud (SOF) (F) (9700; 5536)
  Cesari 2008* (B) (335; 71)
  Gale (B) (800; 756)
  Katzmarzyk (B) (8148; 269)
  Klein (B) (2612; 194)
  Newman* (B) (2292; 286)
  Rantanen (M) (6040; 2900)
  Sasaki (B) (4821; 2407)
  Shibata* (M) (192; 59)
  Shibata* (F) (221; 43)
  Syddall (B) (714; 52)
  Takata* (B) (642; 94)
Overall: I2=89.5%, 95% CI 84% to 93%, P<0.001
Between study variance=0.0002
0.96 (0.95 to 0.97)
0.96 (0.95 to 0.97)
0.97 (0.96 to 0.98)
0.98 (0.96 to 1.00)
0.99 (0.98 to 1.00)
0.98 (0.96 to 1.00)
0.95 (0.93 to 0.97)
0.97 (0.95 to 0.99)
0.97 (0.96 to 0.98)
0.98 (0.97 to 0.98)
1.00 (0.99 to 1.01)
0.99 (0.96 to 1.02)
0.95 (0.91 to 0.99)
0.97 (0.93 to 1.02)
0.97 (0.96 to 0.98)
0.911 1 1.1
Study author/s (sex) (total No; No of deaths)
Hazard ratio per 1 kg increase in grip strength
Hazard ratio
(95% CI)
Fig 3 | Hazard ratios of mortality per 1 kg increase in grip strength with adjustment for age, sex
(where appropriate), and body size. B=both sexes; F=women only; M=men only;
MrOS=Osteoporotic Fractures in Men Study; SOF=Study of Osteoporotic Fractures. *Estimates
adjusted for multiple factors as results from models adjusted for age, sex, and body size were
not available. Adjustments were as follows: Cesari (2008)—age, sex, body mass index (BMI),
cognitive performance, number of clinical conditions, albumin, total cholesterol; Newman—
age, sex, race, height, smoking, physical activity, number of chronic conditions, education,
interleukin-6, Center for Epidemiologic Studies Depression scale (CES-D), DXA body
composition; Shibata—blood pressure, cholesterol, albumin, visual retention, education, BMI,
history of chronic diseases, alcohol, smoking, activities of daily living, electrocardiographic
changes; Takata—sex, smoking, BMI, systolic blood pressure, marital status, total cholesterol,
glucose, complications from prevalent disease
Table 3 | Results from stratified meta-analyses of age, sex, and body size adjusted hazard ratios of associations of walking
speed and chair rise time with all cause mortality: lowest versus highest quarter comparison
Stratification
Walking speed Chair rise time
No*
Summary hazard ratio
(95% CI) I2 (%) P value† No*
Summary hazard
ratio (95% CI) I2 (%) P value†
None 5 2.87 (2.22 to 3.72) 25.2 0.25 5 1.96 (1.56 to 2.46) 81.9 <0.01
Mean age at baseline
(years):
≤60 0 – – – 0 –
61-70 1 6.25 (2.79 to 14.02) – – 0 – 81.9 <0.01
>70 4 2.68 (2.14 to 3.35) 0 0.71 5 1.96 (1.56 to 2.46)
Lengthof follow-up(years):
≤5 4 3.11 (2.37 to 4.09) 13.3 0.33 1 1.90 (1.26 to 2.87) – –
6-10 1 2.16 (1.38 to 3.38) – – 3 2.14 (1.86 to 2.48) 8.7 0.34
11-20 0 – – – 1 1.50 (1.38 to 1.63) – –
>20 0 – – – 0 – – –
Region of study:
North America 2 3.95 (1.89 to 8.28) 61.9 0.11 3 1.85 (1.42 to 2.41) 88.0 <0.01
Japan 0 – – – 0 – – –
Other 3 2.61 (2.02 to 3.37) 0 0.54 2 2.26 (1.58 to 3.23) 27.7 0.24
Sex‡:
Male 4 2.65 (2.01 to 3.48) 0 0.58 3 2.17 (1.82 to 2.58) 17.3 0.30
Female 4 3.19 (2.20 to 4.63) 6.7 0.36 3 1.77 (1.36 to 2.30) 67.0 0.05
*Number of data points.
†From Cochran’s Q statistic.
‡Total numbers differ for sex stratified meta-analyses for following reasons: walking speed quarter comparison estimates include one study of men
only and one study of women only (unstratified summary hazard ratio for comparison 2.83 (2.28 to 3.51), n=8, I2=0%, P=0.56); chair rise time
quarter comparison estimates include two studies of men only and two studies of women only (unstratified summary hazard ratio for comparison
2.00 (1.62 to 2.46), n=6, I2=78.1%, P<0.01).
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Althoughmost of the estimates from comparisons of
quarterswere in the samedirection,we found evidence
of heterogeneity between studies (I2=84.0%, 74% to
90%; P from Q statistic<0.001). When we stratified
meta-analyses (table 1), the association between grip
strength and mortality seemed to be weaker in studies
with an average age at baseline under 60 years com-
paredwith studieswith an older average age at baseline
and also in studieswith follow-upofmore than 20years
compared with studies with shorter follow-up. We
found further evidence of a weaker association
between grip strength and mortality in studies with
longer follow-up in meta-regression analyses compar-
ing the weakest and strongest quarters of grip strength
(P=0.054 from permutation test controlling for multi-
ple testing). The inclusion of follow-up time reduced
the estimate of between study variance from 0.06 to
0.02, and the variation in effect size by follow-up time
was independent of age (P=0.065 for length of follow-
up frompermutation test).We foundno evidence from
meta-regression analyses in support of differences in
summary estimates between categories of the other
pre-specified characteristics, and the removal of each
study from meta-analyses did not greatly affect esti-
mates of the level of heterogeneity.
Of the four studies of grip strength that could not be
included in at least one of the meta-analyses, most
results were consistent with the findings from meta-
analyses (table 2). 15 20 22 28 The one exception was
among women in the study by Fujita et al. 15
Walking speed and mortality
A total of 16 sets of results from analyses of the associa-
tion betweenwalking speed or time andmortalitywere
available; analyses were done in 11 different study
populations. The Hispanic Established Population for
the Epidemiological Study of the Elderly (H-
EPESE)10 35 36 and another unnamed US study1718 24
had both been used three times, and the Health,
Aging and Body Composition (ABC) study had been
used twice,12 14, at different follow-up times (web table
A).
We had seven sets of results in the form of compar-
isons of quarters, but three were based on the same
study population (H-EPESE) and we included only
one set of these (those with the requested standard
adjustments10) in the main meta-analysis. These five
studies (14 692 participants) all found that people in
the slowest quarter of walking speed had significantly
highermortality rates than did those in the fastest quar-
ter (fig 6); the overall summary hazard ratio of mortal-
ity comparing the slowest with the fastest quarter was
2.87 (2.22 to 3.72) with adjustment for age, sex, and
body size. Heterogeneity was moderate (I2=25.2%,
0% to 70%; P from Q statistic=0.25), and the studies
varied little in the pre-specified characteristics that
could have explained this (table 3). Summary hazard
ratios from the meta-analyses of effect estimates com-
paring the second slowest and second fastest quarters
with the fastest quarter were also consistent and
showed a graded effect (fig 5). Findings were similar
when we re-ran meta-analyses including estimates
from the other analyses of H-EPESE in place of those
included in the main meta-analysis; the overall sum-
mary hazard ratios of mortality comparing the slowest
with the fastest quarter estimated from random effects
models were 2.99 (2.24 to 4.00) and 2.58 (1.83 to 3.64)
whenwe included results fromanalyses byMarkides et
al 35 and Ostir et al 36 in place of those provided by Al
Snih et al. 10
The six studies not included in meta-analyses
presented findings consistent with those from the
Grip strength (n=14)
  Lowest quarter
  2
  3
  Highest quarter
Walking speed (n=5)
  Lowest quarter
  2
  3
  Highest quarter
Chair rise time (n=5)
  Lowest quarter
  2
  3
  Highest quarter
1.67 (1.45 to 1.93)
1.28 (1.16 to 1.40)
1.15 (1.07 to 1.24)
1.00
2.87 (2.22 to 3.72)
1.77 (1.45 to 2.17)
1.38 (0.99 to 1.92)
1.00
1.96 (1.56 to 2.46)
1.40 (1.18 to 1.66)
1.24 (1.08 to 1.42)
1.00
1
Hazard ratio of mortality
Summary hazard
ratio (95% CI)
2 3
Fig 5 | Summary hazard ratios of mortality from meta-analyses
comparing each quarter of grip strength, walking speed, and
chair rise time with highest quarter, including results
adjusted for age, sex (where appropriate), and body size
(n=number of data points included in meta-analysis)
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  Anstey (B) (1120; 463)
  Cawthon and Ensrud (MrOS) (M) (5631; 1070)
  Cawthon and Ensrud (SOF) (F) (9700; 5536)
  Gale (B) (800; 756)
  Katzmarzyk (B) (8148; 269)
  Klein (B) (2612; 194)
  Metter (M) (1071; 533)
  Rolland (F) (7050; 722)
  Sasaki (B) (4821; 2407)
  Syddall (B) (714; 52)
  Van den Beld (M) (402; 179)
  Willcox (M) (7992; 6963)
Overall: I2=84.0%, 95% CI 74% to 90%, P<0.001
Between study variance=0.05
1.33 (1.06 to 1.67)
2.41 (1.78 to 3.27)
2.58 (1.76 to 3.76)
2.30 (1.88 to 2.81)
1.43 (1.32 to 1.54)
1.37 (1.09 to 1.72)
1.47 (0.94 to 2.30)
2.79 (1.47 to 5.27)
1.17 (0.86 to 1.60)
1.72 (1.16 to 2.55)
1.98 (1.64 to 2.40)
1.10 (0.49 to 2.47)
2.08 (1.31 to 3.30)
1.22 (1.13 to 1.31)
1.67 (1.45 to 1.93)
0.19 1 5.27
Study author/s (sex) (total No; No of deaths)
Hazard ratio lowest v highest quarter of grip strength
Hazard ratio
(95% CI)
Fig 4 | Hazard ratios of mortality comparing weakest with strongest quarter of grip strength
with adjustment for age, sex (where appropriate), and body size. B=both sexes; F=women only;
M=men only; MrOS=Osteoporotic Fractures in Men Study; SOF=Study of Osteoporotic Fractures
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meta-analyses (table 4). All evidence supported an
association between slower walking speed and higher
mortality.
Chair rise time and mortality
All seven sets of results fromanalyses of the association
between chair rise time and mortality were from
unique studies. Five were in the form of comparisons
of quarters and so could be included in meta-analyses.
These five studies (28 036 participants) all found that
people in the slowest quarter of chair rise time had sig-
nificantly higher mortality rates than did those in the
fastest quarter (fig 7); the overall summary hazard ratio
of mortality comparing the slowest with the fastest
quarter was 1.96 (1.56 to 2.45) with adjustment for
age, sex, and body size. Although all effect estimates
were in the same direction, we found evidence of a
high degree of heterogeneity between studies
(I2=81.9%, 58% to 92%; P from Q statistic<0.001).
When we stratified the meta-analyses by the pre-speci-
fied characteristics (table 3), the effect seemed to be
stronger in men than in women, but we had too few
data points to investigate this further. The variation in
the other characteristics was also insufficient to explain
the heterogeneity, and the removal of each study from
meta-analyses did not affect estimates of the level of
heterogeneity (results not shown). Summary hazard
ratios from the meta-analyses of effect estimates com-
paring the second slowest and second fastest quarters
with the fastest quarter were also consistent and
showed a graded effect (fig 5). Three of the studies
also reported effect estimates from comparisons of
people unable to do chair rises with those in the fastest
quarter; the summary hazard ratio formortality from a
meta-analysis of these three results suggested that those
unable to do chair rises had the highest rates of mortal-
ity (4.09, 2.24 to 4.42).
The findings from the two studies not included in the
meta-analysis (table 4) were consistent with those from
the meta-analysis and also reported that slower chair
rise time was associated with higher mortality.
Standing balance and mortality
All five sets of results from analyses testing the associa-
tion between standing balance and mortality were
  Al Snih* (B) (2185; 381)
  Klein (B) (2556; 161)
  Rolland (F) (7716; 721)
  Van den Beld (M) (402; 179)
  Woo (B) (1833; 408)
Overall: I2=25.2%, 95% CI 0% to 70%, P=0.25
Between study variance=0.02
2.90 (1.83 to 4.60)
6.25 (2.79 to 14.02)
2.52 (1.37 to 4.63)
2.16 (1.38 to 3.38)
3.00 (2.08 to 4.33)
2.87 (2.22 to 3.72)
0.0713 1 14
Study author/s (sex) (total No; No of deaths)
Hazard ratio slowest v fastest quarter of walking speed
Hazard ratio
(95% CI)
Fig 6 | Hazard ratios of mortality comparing slowest with fastest quarter of walking speed with
adjustment for age, sex (where appropriate), and body size. B=both sexes; F=women only;
M=men only. *When results from analyses of H-EPESE by Markides et al and Ostir et al were
included in this meta-analysis in place of Al Snih’s results, the findings were unchanged
Table 4 | Summary of results from studies of walking speed and chair rises not included in meta-analyses
Study name and reference/s*
TotalNo (No
of deaths)
Category comparison/
value of unit change
Effect estimate
(95% CI) Adjustments
Walking speed
Health ABC study, Cesari et al 200512 and
200914
1016
(163)†;
3024 (653)‡
Speed <1.00m/s v ≥1.00
m/s
Relative risk 1.64
(1.14to2.37)†;1.49
(1.23 to 1.80)‡
Age,sex, race, studysite, smoking,BMI,
MMSE score, physical activity,
comorbidities (and also alcohol
consumptionandeducation for 6.9year
follow-up)
ilSIRENTE, Cesari et al 200813 335 (71) Per 1 SD increase Hazard ratio 0.73
(0.54 to 0.99)
Age, sex, BMI, cognitive performance,
No of clinical conditions, albumin, total
cholesterol
Unnamed US study, Hardy et al 200717 and
200818; Perera et al 200524
439 (88) Per 0.1 m/s increase Hazard ratio 0.87
(0.78 to 0.98)§
Age, sex, hospital admission, No of
comorbidities, activities of daily living
EVERGREENproject, Laukkanen et al 199520 466 (74) Below v above mean
speed
Hazard ratio 1.98
(1.18 to 3.34)
Age, sex
Cardiovascular Health Study, Rosano et al
200827
3156 (704) Per 1 m/s increase Hazard ratio 0.87
(0.78 to 0.98)
Age, sex, race, education, digit symbol
substitution test score
Precipitating Events Project, Rothman et al
200828
754 (283) Slow v not slow Hazard ratio 2.7 (2.0
to 3.7)
Age, sex, race, education, chronic
conditions
Chair rises
Health ABC study, Cesari et al 200914 3024 (653) Time for 5 rises ≥
17 seconds v <
17 seconds
Hazard ratio 1.40
(1.17 to 1.68)
Age, sex, race, studysite, smoking,BMI,
MMSE score, physical activity,
comorbidities, alcohol consumption,
education
ilSIRENTE, Cesari et al 200813 335 (71) Per 1SD increase in chair
rise score—from 0
(unable) to 4 (≤
11 seconds)
Hazard ratio 0.51
(0.36 to 0.72)
Age, sex, BMI, cognitive performance,
No of clinical conditions, albumin, total
cholesterol
BMI=body mass index; MMSE=mini-mental state examination.
*See web table A for further details of studies.
†4.9 year follow-up (on restricted sample).
‡6.9 year follow-up (on full sample).
§Results taken from Perera et al 2005,24 but results from two other papers on this study are consistent.17,18
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from unique studies. However, as standing balance
had not beenmeasured and categorised in comparable
ways across studies, we could not do meta-analyses of
these results. Although all five studies found some evi-
dence that poorer performance in standing balance
tests was associated with higher mortality rates, these
associations were not all statistically significant at con-
ventional levels (table 5).
DISCUSSION
We have found evidence of associations between all
four measures of physical capability investigated (grip
strength, walking speed, chair rises, and standing bal-
ance) and all cause mortality. People in community
dwelling populations who perform less well in these
tests were consistently found to be at higher risk of
death. The estimates from meta-analyses for grip
strength, walking speed, and chair rises show a dose-
response relation. With the exception of grip strength,
studies have been done exclusively in older popula-
tions, and most have relatively short follow-up, so
whether similar associations would be found at
younger ages or after participants have been
followed-up for longer than 10 years is unclear. For
grip strength, we found evidence of an association
even in populations with an average age at baseline of
less than 60 years, although the association weakened
with increasing length of follow-up.
Explanation of findings
Several possible explanations exist, which are not
necessarily exclusive, for finding associations between
objectivemeasures of physical capability andmortality
in community dwelling populations. Firstly, these find-
ings could be explained by confounding (for example,
by socioeconomic position or levels of physical activ-
ity), as effect estimates have only been adjusted for age,
sex, and body size. These factors were considered to be
the most likely confounders yet did not explain the
associations of the physical capability measures with
mortality.Apart from these, no standard set ofmultiple
adjustments across papers existed and we thought that
requesting further adjustmentswould have affected the
response from study authors and led to inconsistencies
in adjustments across studies.
Secondly, these measures of physical capability
could be markers of disease and general health status.
Some of the community dwelling populations
included in this review consisted of people with dis-
eases or comorbidities that were not considered severe
enough to warrant exclusion from the study but that
may have affected both their physical performance
andmortality risk. This could definitely apply to walk-
ing speed, chair rises, and standing balance, for which
studies have been done only in older populations with
shorter follow-up. However, this seems less likely to
fully explain associations between grip strength and
mortality, as these were also found in studies with fol-
low-up over 20 years, in younger populations in which
the prevalence of sub-clinical disease and existing
comorbidities would be lower, and in studies that by
Table 5 | Summary of results from studies of standing balance
Study name and reference/
s*
TotalNo (No
of deaths)
Category comparison/value of unit
change
Effect estimate
(95% CI) Adjustments
HealthABCstudy,Cesari etal
200914
3024 (653) Balance <53 seconds v ≥53 seconds (note:
max score 90 seconds)
Hazard ratio 1.35
(1.12 to 1.62)
Age, sex, race, study site, smoking,
BMI, MMSE score, physical activity,
comorbidities, alcohol
consumption, education
ilSIRENTE,Cesarietal200813 335 (71) Per 1SD increase in standingbalance score
—from 0 (unable) to 4 (hold tandem stand
for 10 seconds)
Hazard ratio 0.77
(0.60 to 1.00)
Age, sex, BMI, cognitive
performance, No of clinical
conditions, albumin, total
cholesterol
EPESE, Guralnik et al 199443 5264 (1741) 1) Unable to hold side by side stand v able
to hold tandem stand for 10 seconds; 2)
Able to hold side by side stand for
10 seconds but unable to hold semi-
tandemstand for 10 seconds v able to hold
tandem stand for 10 seconds
1) Hazard ratio 3.54
(3.04 to 4.13); 2)
1.78 (1.51 to 2.09)
Age, sex, height, weight
EPIDOS study, Rolland et al
200626
7092 (722) Lowest (0-20 seconds) v highest third (
27-30 seconds)
Hazard ratio 1.57
(1.32 to 1.87)
Age, sex, body mass index
Study of Fukuoka Prefecture
residents, Takata et al
200732
551 (72) Per 1 unit change in balance time Hazard ratio 0.99
(0.97 to 1.01)
Sex, smoking, BMI, systolic blood
pressure, marital status, total
cholesterol, glucose, complications
from prevalent disease
BMI=body mass index; MMSE=mini-mental state examination.
*See web table A for further details of studies.
  Cawthon and Ensrud (MrOS) (M) (5712; 1091)
  Cawthon and Ensrud (SOF) (F) (9688; 5509)
  Guralnik (B) (5231; 1423)
  Rolland (F) (7012; 721)
  Van den Beld (M) (393; 176)
Overall: I2=81.9%, 95% CI 58% to 92%, P<0.001
Between study variance=0.05
1.96 (1.62 to 2.37)
1.50 (1.38 to 1.63)
2.25 (1.82 to 2.78)
1.90 (1.26 to 2.87)
2.74 (1.75 to 4.30)
1.96 (1.56 to 2.45)
0.233 1 4.3
Study author/s (sex) (total No; No of deaths)
Hazard ratio slowest v fastest quarter of chair rise time
Hazard ratio
(95% CI)
Fig 7 | Hazard ratios of mortality comparing slowest with fastest quarter of chair rise time with
adjustment for age, sex (where appropriate), and body size. B=both sexes; F=women only;
M=men only; MrOS=Osteoporotic Fractures in Men Study; SOF=Study of Osteoporotic Fractures
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the nature of their design (for example, recruitment of
men from the active workforce) excluded people with
health problems.25
A related possibility is that underlying ageing pro-
cesses led to poorer performance and a higher prob-
ability of chronic disease and death. Walking speed,
chair rising, and standing balance require strength, bal-
ance, and motor control; walking speed and chair ris-
ing also requiremuscle power and speed and adequate
cardiorespiratory function; standing balance requires
mental concentration. These functions decline with
age, may co-vary, and contribute to the risk of frailty.
The progressive dysregulation of homoeostatic equili-
brium across multiple systems may be the biological
basis of frailty; common pathways proposed include
endocrine dysfunction, inflammation, oxidative stress,
and disequilibrium between the sympathetic and para-
sympathetic systems.55
Functional status in later life reflects the peak
achieved during growth and development, as well as
the rate of decline. Thus, the relation between these
measures of physical capability, even when measured
at younger ages, and mortality could also reflect initial
differences in development that affect both. Evidence
that early growth, cognitive and motor development,
and childhood social environment are associated with
adult physical capability, chronic disease, and mortal-
ity support this possibility.56-62
Heterogeneity
Many of the estimates of I2 calculated in these meta-
analyses would be judged to be high.49 We have pre-
sented summary, overall estimates frommeta-analyses
despite this, as most effect estimates from individual
studies were in the same direction and doingmeta-ana-
lyses has been argued to still be appropriate.63 64
Furthermore, the value of I2 depends on both the
within study and the between study variance,48 65 and
asmany of the studies included in this review have pre-
cise estimates (figs 3 and 4), either because the study
population was large or a high proportion of partici-
pants died, the values of I2 will have been affected by
this. However, these summary estimates, which are an
average of estimates across populations with different
characteristics, should be cited with caution, and the
reasons for finding these levels of heterogeneity should
be explored.
Insufficient variation often existed in the character-
istics we proposed a priori as possible sources of het-
erogeneity to allow us to examine their role in
explaining heterogeneity fully—for example, four of
the five studies of walking speed and all five studies of
chair rise time included inmeta-analyses were in popu-
lations aged over 70. However, meta-regression ana-
lyses of comparisons of quarters of grip strength
suggested that associations withmortality were weaker
in those studies with longer follow-up, even after
adjustment for age. Comorbidities at the time of assess-
ment of capability, which would increase short term
mortality, may be more likely to explain the associa-
tion between grip strength andmortality in studieswith
shorter follow-up.With increasing length of follow-up,
the proportional hazards assumption within a study
may be violated.
In addition to the characteristics investigated, many
others vary between studies and could result in hetero-
geneity. These include differences in exclusion criteria,
the instruments used, the main causes of death, levels
of underlying comorbidity, and ethnic diversity.
Implications
This review has highlighted the paucity of studies that
have measured physical capability in younger popula-
tions with subsequent follow-up for mortality. This
situation is expected to change; these measures are
being introduced in studies of younger populations as
overall markers of functioning at the multi-system
level, rather than as markers of severity and stage of
specific chronic diseases.66 However, investigation of
associations with mortality in studies with measure-
ment of capability at younger ages will obviously
need lengthy follow-up. Research is also needed to
examine the associations between changes in capabil-
itywith age andmortality, as a steep decline in physical
capabilitymay be a better predictor ofmortality than is
the absolute level at a single point in time. In addition,
associations between thesemeasures and cause specific
mortality and other health outcomes may help to elu-
cidate the pathways underlying the associations with
all cause mortality, although few studies identified
reported on these. Elucidating the underlying biologi-
cal pathways that link poorer capability to mortality
will inform the development of effective interventions.
We chose to examine the relation between each indi-
vidual measure of physical capability, by using a stan-
dardised exposure measurement (comparisons of
quarters), and mortality. The rationale behind this is
that a variety of composite scores exist that are derived
by using these measurements in combination, but
whether results with such scores are driven by one
measure orwhether they eachmake a similar contribu-
tion is unclear. Although our findings suggest that all
four measures of physical capability assessed are asso-
ciated with all cause mortality, the relative paucity of
data for walking speed, chair rises, and standing bal-
ance makes us cautious about drawing conclusions on
their relative strengths. As these measures of physical
capability are highly correlated with each other, more
studies are needed that consider the value of each addi-
tional test once the findings for one test are known.14
For clinical practice, investigating whether a derived
composite score representing overall lower or upper
body function, such as the short physical performance
battery score43 or one of the frailty indices, may be a
stronger predictor of mortality than any of the indivi-
dual measures are by themselves would be of interest.
The associations found between measures of physi-
cal capability and mortality seem to operate across the
whole range of ability, with no apparent threshold
effect. Therefore, if these measures were to be used as
screening tools, clinicians and researchers would need
to identify thresholds with caution and recognise that
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differences in the most appropriate place to set these
may exist, depending on the characteristics of the
population to be screened. Ultimately, randomised
controlled trials will be needed to determine whether
interventions aimed at improving physical capability
are effective at improving capability and as a conse-
quence are effective at reducing morbidity and
mortality.
Strengths and limitations
The main strengths of this systematic review are its
inclusion of several measures of physical capability
and its inclusion of asmany relevant studies as possible
by making contact with study authors. By following a
strict protocol, testing a priori hypotheses, and includ-
ing unpublished results, we have minimised bias.
The study also has some limitations, although none
of these affects our conclusions. Results from each
study are based on the assumption of proportional
hazards, which may not hold in all studies. The meta-
regression analyses were likely to be underpowered, as
were the formal tests of publication bias, especially for
walking speed and chair rises for which we had less
than the recommended number of data points. That
the funnel plots and formal statistical tests produced
no clear evidence of publication bias should thus be
interpreted with caution. However, our success in
obtaining unpublished results should limit publication
bias.
Conclusions
This review shows the value of objective measures of
physical capability as predictors of subsequent mortal-
ity in older community dwelling populations. Grip
strengthmeasured at younger ages also predictedmor-
tality, but whether walking speed, chair rise time, and
standing balance performance are associated with
mortality in younger populations remains to be seen.
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